Applied Clinical Trials-04-01-2022

In an era of rising healthcare expenses, reassurance about costs for patients in diverse communities is particularly important.

Assessing the benefits of digital adherence monitoring for sites and patients.

Alleviating sponsor and investigator concerns around sharing of remote-assessment data in accordance with GCP and GDPR standards.

How DCTs can impact pharmaceutical companies exploring DTx combination products and standalone DTx studies.

Latest CISCRP study provides insight on proactive outreach.

Rik de Greef, senior vice president of global quantitative science services at Certara discusses the organization's training initiatives in Africa.

Moving forward in a DCT world.

Click the title above for a link to open the Applied Clinical Trials April 2022 issue in an interactive PDF format.

Leaked draft gives glimpse into potential new research proposals as part of the EU’s Horizon program.

Measures being mulled to reform the AA process and address public concerns around its risk-benefit payoff.

This article sets out a vision of adopting convenient alternative blood sampling approaches that places the needs of the patient at the center and enables active monitoring, before the onset of clinical events, leading to improved healthcare.